Author

Emrich Tilman

Observed names: Emrich, Tilman, Emrich, Tilman Stephan, Tilman Emrich, Tilman, Emrich

Institutions: Medical University of South Carolina, Johannes Gutenberg University Mainz, University Medical Center of the Johannes Gutenberg University Mainz

Observed institutions: Medical University of South Carolina, Pfizer (United States), Johannes Gutenberg University Mainz, University Medical Center of the Johannes Gutenberg University Mainz, German Centre for Cardiovascular Research

ORCID: 0000-0003-4156-7727

Observed ORCID: 0000-0003-4156-7727

OpenAlex ID: A5111051072

Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocol

2023 · Michael Pavlides, Ferenc E. Mózes, et al. · Contemporary Clinical Trials · 16

Prospective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging Study

2026 · Michael Pavlides, Yasaman Vali, et al. · Nature Medicine · 11

Acute right ventricular response to transcatheter tricuspid valve replacement

2026 · Cristian Herrera-Flores, Sebastian Rosch, et al. · EuroIntervention · 1

ALBI ‐6—A Novel Prognostic Score Combining ALBI and Interleukin‐6 in Patients With HCC Treated With Atezolizumab and Bevacizumab

2026 · Paula Bark, Lucas Wiesmann, et al. · Alimentary Pharmacology & Therapeutics · 1

Adverse Remodeling and Fibrosis Predict Outcomes in Excessive Trabeculation of the Left Ventricle

2026 · Guillem Casas, Eduard Rodenas-Alesina, et al. · JACC. Cardiovascular imaging

Is the myocardium viable or not?

2021 · Emrich Tilman

Works count: 24

Citation count: 48

H-index: 3

I10-index: 3